In this free webinar, understand the key benefits of master protocols. Attendees will identify the key challenges of master protocols and strategies to address them. The featured speakers will discuss ...

The future of clinical research depends on people just as much as strong systems and processes. Learn what makes great ...

As the curtain closed on 2024, FDA issued a new draft guidance to assist clinical trial sponsors, investigators, and institutional review boards (“IRBs”) with defining, identifying, and reporting ...

A clinical trial protocol is the foundation of clinical research, detailing objectives, study design, eligibility, safety oversight, and data analysis. Its structure ensures consistency and ...

Showcases Use of Causal Machine Learning and IBD Plexus(R) to Optimize Trial Execution BOSTON, Jan. 22, 2026 /PRNewswire/ -- PhaseV, a leader in AI/ML for clinical development, is today presenting new ...

Passage Bio reports positive Phase 1/2 trial results for PBFT02 in frontotemporal dementia, with planned protocol amendments for safety optimization. Passage Bio, Inc. announced positive results from ...

The Subject Expert Committee (SEC) of the Central Drugs Standard Control Organisation (CDSCO) has recommended grant of ...

The approval of this accelerated pathway not only demonstrates the FDA’s full recognition of the quality, safety, and efficacy of the Phase 1 clinical data of hNPC01 in China, but also will ...

Good morning, everyone, and welcome to Intellia Therapeutics conference call. My name is Jamie, and I will be the conference operator today. Please be advised that this call is being recorded at the ...